Skip to main content
An official website of the United States government

Related NCI Initiatives

Cancer-specific proteins, present in low concentrations in the blood, are detected by capturing them on magnetic sensors and tagging them with magnetic nanoparticles by the MagArray device devloped by Stanford University Professor Shan Wang.

Credit: National Cancer Institute & Stanford University

The National Cancer Institute has recognized that the achievement of 21st century personalized cancer care requires a commitment to a new kind of scientific enterprise. Such an enterprise is characterized by “team science” across multiple laboratories that share data in standardized formats; collaborations among academic, private, and public sector organizations; and high-throughput technology platforms supported by seamless informatics capability and systems-level planning and management. The technology initiatives launched through the NCI, including the Alliance for Nanotechnology in Cancer, are positioned to support this transformation in cancer research for better prevention, diagnosis, and treatment of cancer and improved outcomes for patients.

Learn about the offices within the NCI's Division of Cancer Treatment and Diagnosis by visiting each program website:

Learn about other complementary NCI initiatives:

  • Updated: